ABIVAX to Present at upcoming Investors Conferences

Paris, November 15th, 2016 – ABIVAX (Euronext Paris: FR0012333284 – ABVX), an innovative biotechnology company targeting the immune system to eliminate viral disease, today announced that senior management of ABIVAX will present and host investor meetings at the following upcoming investor events:

German Equity Forum from November 21st to 23rd at the Sheraton Frankfurt Airport Hotel and Conference Center in Frankfurt am Main (Germany). Prof. Hartmut Ehrlich, M.D., CEO of ABIVAX will present on Tuesday, November 22nd at 3:00pm – 3:30pm CET in Room Oslo.

To schedule investor or media meetings with ABIVAX management at the German Equity Forum, please contact: This email address is being protected from spambots. You need JavaScript enabled to view it..">This email address is being protected from spambots. You need JavaScript enabled to view it..

28th Annual Piper Jaffray Healthcare Conference from November 29th to 30th at the Lotte New York Palace Hotel in New York, NY. Prof. Hartmut Ehrlich, M.D., CEO of ABIVAX will participate in a fireside chat on Tuesday, November 29th, from 4:30 to 4:55 PM EST.

To schedule investor or media meetings with ABIVAX management at the Piper Jaffray Healthcare Conference, please contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Press contacts

Caroline Carmagnol 

abivax@alizerp.com

+ 33 6 64 18 99 59 or
+ 33 1 44 54 36 65

 Standard: +33 1 53 83 08 41